BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1304 related articles for article (PubMed ID: 11434449)

  • 1. Newer neuromuscular blocking agents: how do they compare with established agents?
    Sparr HJ; Beaufort TM; Fuchs-Buder T
    Drugs; 2001; 61(7):919-42. PubMed ID: 11434449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapacuronium bromide: a review of its use in anaesthetic practice.
    Onrust SV; Foster RH
    Drugs; 1999 Nov; 58(5):887-918. PubMed ID: 10595867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics of the newer neuromuscular blocking drugs.
    Atherton DP; Hunter JM
    Clin Pharmacokinet; 1999 Mar; 36(3):169-89. PubMed ID: 10223167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of rapacuronium bromide.
    Wight WJ; Wright PM
    Clin Pharmacokinet; 2002; 41(13):1059-76. PubMed ID: 12403643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New muscle relaxants].
    Diefenbach C; Buzello W
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Feb; 31(1):2-8. PubMed ID: 8868525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromuscular interaction between cisatracurium and mivacurium, atracurium, vecuronium or rocuronium administered in combination.
    Kim KS; Chun YS; Chon SU; Suh JK
    Anaesthesia; 1998 Sep; 53(9):872-8. PubMed ID: 9849281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The clinical pharmacology of new benzylisoquinoline-diester compounds, with special consideration of cisatracurium and mivacurium].
    Savarese JJ; Lien CA; Belmont MR; Wastila WB
    Anaesthesist; 1997 Oct; 46(10):840-9. PubMed ID: 9424966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rocuronium priming of atracurium-induced neuromuscular blockade: the use of short priming intervals.
    Abdulatif M; al-Ghamdi A; el-Sanabary M
    J Clin Anesth; 1996 Aug; 8(5):376-81. PubMed ID: 8832448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rocuronium bromide in dental day case anaesthesia--a comparison with atracurium and vecuronium.
    Chetty MS; Pollard BL; Wilson A; Healy TE
    Anaesth Intensive Care; 1996 Feb; 24(1):37-41. PubMed ID: 8669652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choice of the muscle relaxant for rapid-sequence induction.
    Sparr HJ
    Eur J Anaesthesiol Suppl; 2001; 23():71-6. PubMed ID: 11766251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of atracurium, cisatracurium and vecuronium during anaesthesia for laparoscopic surgery].
    Paśko-Majewska M; Owczuk R; Wujtewicz M
    Anestezjol Intens Ter; 2011; 43(1):9-13. PubMed ID: 21786523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapacuronium: clinical pharmacology.
    Mirakhur RK; McCourt KC
    Eur J Anaesthesiol Suppl; 2001; 23():77-82. PubMed ID: 11766252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromuscular blocking effects and train-of-four fade with cisatracurium: comparison with other nondepolarising relaxants.
    Carroll MT; Mirakhur RK; Lowry DW; McCourt KC; Kerr C
    Anaesthesia; 1998 Dec; 53(12):1169-73. PubMed ID: 10193219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability of duration of action of neuromuscular-blocking drugs in elderly patients.
    Arain SR; Kern S; Ficke DJ; Ebert TJ
    Acta Anaesthesiol Scand; 2005 Mar; 49(3):312-5. PubMed ID: 15752394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisatracurium besilate. A review of its pharmacology and clinical potential in anaesthetic practice.
    Bryson HM; Faulds D
    Drugs; 1997 May; 53(5):848-66. PubMed ID: 9129870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onset/offset characteristics and intubating conditions of rapacuronium: a comparison with rocuronium.
    Zhou TJ; White PF; Chiu JW; Joshi GP; Dullye KK; Duffy LL; Tongier WK
    Br J Anaesth; 2000 Aug; 85(2):246-50. PubMed ID: 10992833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapacuronium: first experience in clinical practice.
    Bartkowski RR; Witkowski TA
    Eur J Anaesthesiol Suppl; 2001; 23():90-3. PubMed ID: 11766254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Edrophonium effectively antagonizes neuromuscular block at the laryngeal adductors induced by rapacuronium, rocuronium and cisatracurium, but not mivacurium.
    Suzuki T; Lien CA; Belmont MR; Tjan J; Savarese JJ
    Can J Anaesth; 2003 Nov; 50(9):879-85. PubMed ID: 14617582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atracurium, cisatracurium, vecuronium and rocuronium in patients with renal failure.
    Della Rocca G; Pompei L; Coccia C; Costa MG; Cecchini V; Vilardi V; Pietropaoli P
    Minerva Anestesiol; 2003; 69(7-8):605-11, 612, 5. PubMed ID: 14564242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of intubating conditions after rapacuronium (Org 9487) and succinylcholine following rapid sequence induction in adult patients.
    Sparr HJ; Mellinghoff H; Blobner M; Nöldge-Schomburg G
    Br J Anaesth; 1999 Apr; 82(4):537-41. PubMed ID: 10472218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.